Egyptian Board Thoracic Diseases common mistakes
Egyptian Board Thoracic Diseases · Understand the traps and how to avoid them.
Calculating the alveolar-arterial oxygen gradient with the simplified alveolar gas equation while ignoring the respiratory quotient and CO2 term, then labelling a mildly raised gradient as a shunt; or alternatively treating every hypoxaemia as shunt without checking whether it corrects with supplemental oxygen.
Candidates memorise PAO2 = FiO2 × (Patm − 47) − PaCO2/0.8 as a single formula and drop the RQ term under exam pressure. Because the exam often gives PaCO2 values well above 40 mmHg, omitting the /0.8 division underestimates the gradient and misclassifies the physiology. The shunt-versus-V/Q distinction is also conflated because both cause hypoxaemia that does not fully correct with oxygen in severe cases.
What to do instead
Write the full equation each time: PAO2 = FiO2(Patm − 47) − (PaCO2/R), using R = 0.8 unless stated. Then compute A-a gradient and, separately, the PaO2/FiO2 ratio. Use the response to 100% oxygen as a discriminator: true shunt (e.g. dense consolidation, atelectasis) raises PaO2 only marginally, whereas V/Q mismatch and diffusion limitation improve substantially. Practise 5 calculations per session with PaCO2 values of 60–80 mmHg so the division becomes automatic.
Interpreting spirometry without applying the post-bronchodilator criterion and the lower limit of normal: calling a fixed ratio below 0.70 COPD in a 75-year-old without checking the age-adjusted LLN, or diagnosing asthma on a single pre-bronchodilator trace with a borderline FEV1/FVC.
The 0.70 fixed ratio is over-learned from COPD guidelines and applied to every age group, while the LLN concept is under-practised. Candidates also forget that asthma diagnosis requires demonstrating variability (reversibility ≥12% and ≥200 mL, or serial peak flow variability), not just obstruction. Spirometry quality criteria (acceptable effort, back-extrapolated volume, reproducibility) are rarely checked in exam vignettes.
What to do instead
For every spirometry vignette, state three things explicitly: (1) is the trace technically acceptable and reproducible; (2) FEV1/FVC versus LLN for the patient's age, sex and height; (3) post-bronchodilator change in absolute mL and percent. Reserve COPD for persistent post-bronchodilator obstruction with compatible exposure history; reserve asthma for documented variability. Build a one-page decision grid and rehearse it on borderline cases.
Managing acute severe asthma with the same inhaled bronchodilator and steroid regimen used for mild exacerbations, omitting ipratropium, magnesium sulphate, and early controlled oxygen targeting SpO2 93–95%, while over-relying on theophylline or sedatives.
Candidates conflate chronic asthma step-therapy with acute exacerbation protocols, and the exam deliberately includes distractors such as sedation for agitation or routine antibiotics. The controlled oxygen target is frequently missed because candidates apply the COPD target (88–92%) to all obstructive disease.
What to do instead
Memorise the acute severe asthma bundle as a sequence: controlled oxygen to 93–95%, repeated salbutamol with ipratropium in severe cases, early systemic corticosteroids, intravenous magnesium sulphate for poor response, and consideration of IV salbutamol or aminophylline only in refractory cases in critical care. Explicitly reject sedation and routine antibiotics. Note the COPD contrast: target 88–92% in those at risk of hypercapnia.
Reading a chest radiograph or CT report as a diagnosis rather than a pattern: labelling a cavitary upper-lobe lesion as tuberculosis without considering malignancy, and treating a solitary pulmonary nodule as benign because it is small, without applying size, morphology, and growth criteria.
Exam vignettes reward pattern recognition, so candidates jump from 'upper lobe cavitation' to TB and stop. They also under-use the Fleischner-style follow-up logic for incidental nodules and forget that a cavitating squamous cell carcinoma or an abscess can mimic TB. Sputum acid-fast bacilli negativity is often misinterpreted as excluding TB.
What to do instead
For every cavitary or nodular lesion, list a differential of at least four causes with discriminating features (wall thickness, location, calcification, satellite nodules, clinical exposure). State the next test, not just the likely diagnosis: sputum Xpert MTB/RIF and culture for suspected TB, contrast CT and PET or biopsy for a suspicious nodule. Apply size-based follow-up rules explicitly in the answer rather than vague 'reassurance'.
Attributing bilateral basal reticulation and honeycombing to idiopathic pulmonary fibrosis without excluding the known causes, and failing to recognise the exposure history (bird fancier's, farmer's lung, asbestos, silica) that changes the diagnosis and management.
IPF is the most familiar ILD pattern, so candidates anchor on it. Occupational and hypersensitivity pneumonitis histories are embedded in the vignette but treated as background colour. Candidates also confuse the UIP pattern on HRCT with the diagnosis of IPF, forgetting that UIP can be secondary to connective tissue disease or drug toxicity.
What to do instead
Adopt a mandatory checklist for every ILD vignette: exposure history (occupation, hobbies, birds, mould, drugs), autoimmune features, and HRCT pattern (UIP, NSIP, organising pneumonia, hypersensitivity). State that a UIP pattern plus an identifiable cause is not IPF. For occupational disease, name the exposure, latency, and the specific surveillance or compensation implication.
Ordering D-dimer as a rule-out for pulmonary embolism in a patient with a high pre-test probability or a Wells score that already mandates imaging, and failing to apply age-adjusted D-dimer cut-offs in patients over 50.
D-dimer is taught as 'the PE test', so candidates apply it indiscriminately. The exam tests the algorithm: PERC for low-risk rule-out, Wells or Geneva for stratification, age-adjusted D-dimer for intermediate probability, and CT pulmonary angiography for high probability. Candidates also forget that D-dimer is unhelpful in pregnancy, malignancy, and recent surgery.
What to do instead
Rehearse the PE pathway as a flowchart: PERC (if all negative, no testing) → Wells → if low/intermediate, D-dimer with age adjustment (age × 10 µg/L FEU above 50) → if positive or high probability, CTPA. State explicitly when D-dimer must not be used. Add a line on pregnancy (leg ultrasound then V/Q or CTPA per local protocol) and on massive PE (thrombolysis before imaging if unstable).
Interpreting apnoea-hypopnoea index and oxygen desaturation index in isolation, missing the distinction between obstructive and central events, and dismissing obesity hypoventilation or Cheyne-Stokes respiration as 'just OSA'.
Candidates fixate on the AHI number and severity bands, and treat the sleep study as a single diagnostic label. Central sleep apnoea, Cheyne-Stokes in heart failure, and obesity hypoventilation syndrome require different management (adaptive servo-ventilation, bilevel, weight management), and the exam tests this differentiation.
What to do instead
For every sleep vignette, report four things: AHI with event type breakdown, ODI, awake and sleep PaCO2 or bicarbonate if available, and comorbidities (heart failure, obesity, opioids). State the diagnosis with subtype and the treatment implication. Flag that AHI alone does not define severity when symptoms or hypoxaemia are disproportionate.
Staging lung cancer by clinical intuition rather than the TNM system, and treating a malignant pleural effusion or a solitary metastasis as curable-stage disease; also failing to distinguish small-cell from non-small-cell management pathways.
TNM descriptors are numerous and candidates remember only the broad stages. Pleural effusion (M1a) and separate tumour nodules in another lobe (M1a) are under-recognised as metastatic. Small-cell lung cancer is often incorrectly offered surgery because the vignette describes a peripheral nodule.
What to do instead
Memorise the TNM groupings that change management: T3 versus T4, N1 versus N2 versus N3, M1a (contralateral lung nodule, pleural/pericardial effusion) versus M1b (single extrathoracic) versus M1c (multiple). State stage and the modality (surgery, chemoradiotherapy, palliative) for each vignette. Explicitly note that limited-stage SCLC is treated with chemoradiotherapy, not resection, and that pleural effusion with malignant cells is stage IV.
Setting ventilator parameters by habit rather than by lung-protective targets: using tidal volumes of 10–12 mL/kg predicted body weight, tolerating high plateau pressures, and failing to recognise auto-PEEP or patient-ventilator dyssynchrony in obstructive disease.
Candidates confuse actual body weight with predicted body weight and default to 'normal' ventilator settings. The exam tests ARDSnet targets (6 mL/kg PBW, plateau ≤30 cmH2O), permissive hypercapnia, and the management of dynamic hyperinflation in asthma and COPD (low rate, long expiratory time, watch auto-PEEP).
What to do instead
For every ventilation vignette, calculate predicted body weight from height and sex, then state tidal volume, plateau pressure, driving pressure, and PEEP. In obstructive disease, state respiratory rate, I:E ratio, and the measured auto-PEEP with the action taken. In ARDS, state the target plateau and the recruitment or prone-positioning threshold (PaO2/FiO2 <150).
Managing paediatric respiratory presentations with adult thresholds and drug doses: applying adult asthma severity criteria to a child, missing the significance of grunting, nasal flaring, and recession in bronchiolitis, and prescribing adult-sized inhaled or systemic steroid doses.
Adult training dominates, and candidates transfer adult cut-offs (peak flow percentages, oxygen targets, steroid doses) to children. Bronchiolitis is frequently over-treated with bronchodilators and steroids despite evidence against routine use, and the exam tests this evidence-based restraint.
What to do instead
For paediatric vignettes, state the age-specific normal ranges and weight-based doses explicitly. For bronchiolitis, state supportive care (oxygen, hydration, respiratory support) and explicitly justify withholding routine bronchodilators, steroids, and antibiotics. For paediatric asthma, use the severity criteria based on speech, feeding, and work of breathing, and quote the weight-based dose of salbutamol and prednisolone.